Submission Details
| 510(k) Number | K231616 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 02, 2023 |
| Decision Date | August 31, 2023 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K231616 is an FDA 510(k) clearance for the ZEUS IFA(TM) nDNA Test System, ZEUS dIFine, a Anti-dna Indirect Immunofluorescent Solid Phase (Class II — Special Controls, product code KTL), submitted by Zeus Scientific (Branchburg, US). The FDA issued a Cleared decision on August 31, 2023, 90 days after receiving the submission on June 2, 2023. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5100.
| 510(k) Number | K231616 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 02, 2023 |
| Decision Date | August 31, 2023 |
| Days to Decision | 90 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | KTL — Anti-dna Indirect Immunofluorescent Solid Phase |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5100 |